Virtual NCCN Academy 2020 - Part 2: Panel Discussion: Meet the NCCN Guidelines Panel Experts
Topics Discussed:
Panel Discussion: Meet the NCCN Guidelines Panel Experts
Robert W. Carlson, MD, Chief Executive Officer
National Comprehensive Cancer Network
Daniel Chung, MD, Director, Center for Cancer Risk Analysis
Massachusetts General Hospital Cancer Center
Member, NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal Panel
Ruth O’Regan, MD, Division Head of Hematology and Oncology, Associate Director for Clinical Research
University of Wisconsin Carbone Cancer Center
NCCN Board of Directors, Vice-Chair
Member, Breast Cancer Panel
John A. Thompson, MD, Medical Director, Phase I Clinical Trials Program
Professor, Division of Oncology
Member, Clinical Research Division
Fred Hutchinson Cancer Research Center/ Seattle Cancer Care Alliance
Chair, NCCN Guidelines for Management of Immunotherapy-Related Toxicities Panel
Alan P. Venook, MD, FASCO
The Madden Family Distinguished Professor of Medical Oncology and Translational Research
Shorenstein Associate Director, Program Development
UCSF Helen Diller Family Comprehensive Cancer Center
Vice-Chair, NCCN Guidelines for Colon Cancer and Rectal Cancer Panel
Closing Remarks
Gary J. Weyhmuller, MBA, SPHR
Executive Vice President, Chief Operating Officer, National Comprehensive Cancer Network
NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical & Biotech Business Overview:
During this interactive online program, pharmaceutical and biotechnology professionals are given the rare opportunity to view the oncology space, its future and its current operational issues from the provider, advocacy, and payer perspectives. Through this pharmaceutical and biotech training program, participants will improve their working knowledge of key business, policy, coverage, reimbursement, informational, and operational issues in oncology while gathering valuable insights into developing effective strategies for navigating the cancer care ecosystem. Pharmaceutical and biotech professionals will learn from key stakeholders what they view to be the most pressing issues in oncology today and how to apply this knowledge to create mutually-successful working relationships.
This free online program was held on June 29, 2020.
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.
Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCNvideo?s...
Connect with us!
Twitter: / nccn
LinkedIn: / nccn
Facebook: / nccnorg
Instagram: / nccnorg